Next Day Disclosure Return
Filed with HKEX · Stock code 6938 ·
6ix is reading this filing.
View original source (HKEXnews)Suzhou Ribo Life Science Co. Ltd. on 6ix
Earlier from Suzhou Ribo Life Science
- Discloseable and connected transaction acquisition of the remaining 49.71% shareholding in a subsidiary involving the issue of consideration shares under Specific mandate; and proposed change of registered capital and amendments to the articles of association
- Voluntary announcement - phase i clinical trial application submission of RBD3133 injection for overweight and obesity
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- 2026 Interim report
- Ribo Announces Strategic Collaboration with Insilico Medicine to Accelerate siRNA Drug Development Driven by AI
Follow Suzhou Ribo Life Science into a list and get an email when it puts out news.
Follow Suzhou Ribo Life Science